Literature DB >> 17529863

Recurrent systemic pneumococcal disease in children.

Edward O Mason1, Ellen R Wald, Tina Q Tan, Gordon E Schutze, John S Bradley, William J Barson, Laurence B Givner, Jill Hoffman, Sheldon L Kaplan.   

Abstract

BACKGROUND: Recurrent systemic pneumococcal infection usually occurs in immunocompromised patients and patients with underlying conditions.
METHODS: Between 1993 and 2006, investigators at 8 pediatric hospitals prospectively identified cases of invasive pneumococcal disease (IPD) and retrospectively documented demographics and clinical information. Antibiotic susceptibility was determined for penicillin and ceftriaxone by microbroth dilution. Isolates were serotyped and molecular relatedness determined using pulse field gel electrophoresis (PFGE).
RESULTS: Four thousand sixty-seven children were diagnosed with IPD over 12.3 years. One hundred and 8 episodes of recurrent disease were seen in 90 children (2.6%); 75 experienced 2 infections, 12 experienced 3 infections and 3 experienced 4 infections. Fourteen of the 15 children with >2 episodes of infection had underlying conditions. The mean duration between 1st and 2nd infection was 22.9 weeks for children with no known underlying condition and 43.0 weeks for children with an underlying condition (P = 0.001). Seventy episodes of IPD among the 90 patients were caused by a different serotype or a different genotype as demonstrated by the PFGE. Sixteen children had intervals <30 days between infections; 7 were caused by different strains.
CONCLUSIONS: Approximately 80% of the children with recurrent invasive pneumococcal disease had underlying conditions. Seven of 16 children with recurrent infection <30 days apart were caused by acquisition of a new strain. Relapse of infection requires documentation that the pneumococcal isolates are not only the same serotype but also have the same PFGE patterns.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17529863     DOI: 10.1097/INF.0b013e31805ce277

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  10 in total

1.  Concerted action of lactate oxidase and pyruvate oxidase in aerobic growth of Streptococcus pneumoniae: role of lactate as an energy source.

Authors:  Hiroaki Taniai; Ken-ichiro Iida; Masanori Seki; Mitsumasa Saito; Susumu Shiota; Hiroaki Nakayama; Shin-ichi Yoshida
Journal:  J Bacteriol       Date:  2008-03-14       Impact factor: 3.490

2.  Invasive pneumococcal disease in children can reveal a primary immunodeficiency.

Authors:  Jean Gaschignard; Corinne Levy; Maya Chrabieh; Bertrand Boisson; Cécile Bost-Bru; Stéphane Dauger; François Dubos; Philippe Durand; Joël Gaudelus; Dominique Gendrel; Christèle Gras Le Guen; Emmanuel Grimprel; Gaël Guyon; Catherine Jeudy; Eric Jeziorski; Francis Leclerc; Pierre-Louis Léger; Fabrice Lesage; Mathie Lorrot; Isabelle Pellier; Didier Pinquier; Loïc de Pontual; Philippe Sachs; Caroline Thomas; Pierre Tissières; Frédéric V Valla; Philippe Desprez; Véronique Frémeaux-Bacchi; Emmanuelle Varon; Xavier Bossuyt; Robert Cohen; Laurent Abel; Jean-Laurent Casanova; Anne Puel; Capucine Picard
Journal:  Clin Infect Dis       Date:  2014-04-23       Impact factor: 9.079

3.  Recurrent pneumococcal invasive disease in the region of Madrid during a five-year period.

Authors:  J C Sanz; I Rodríguez-Avial; E Ríos; B Ramos; E Cercenado
Journal:  Infection       Date:  2013-12-22       Impact factor: 3.553

4.  Pathogen-specific circulating plasmablasts in patients with pneumonia.

Authors:  Nina V Palkola; Sari H Pakkanen; Jussi M Kantele; Niina Rossi; Ritvaleena Puohiniemi; Anu Kantele
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

5.  Immunodeficiency among children with recurrent invasive pneumococcal disease.

Authors:  Helene Ingels; Lone Schejbel; A C Lundstedt; Lise Jensen; Inga A Laursen; Lars P Ryder; Niels H H Heegaard; Helle Konradsen; Jens Jørgen Christensen; Carsten Heilmann; Hanne V Marquart
Journal:  Pediatr Infect Dis J       Date:  2015-06       Impact factor: 2.129

6.  Recurrent invasive pneumococcal disease in children: underlying clinical conditions, and immunological and microbiological characteristics.

Authors:  Laia Alsina; Maria G Basteiro; Hector D de Paz; Melania Iñigo; Mariona F de Sevilla; Miriam Triviño; Manel Juan; Carmen Muñoz-Almagro
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

7.  Clinical Presentations and Outcomes of Children in Canada With Recurrent Invasive Pneumococcal Disease From the IMPACT Surveillance Network.

Authors:  Yousif Murad; Te-Yu Hung; Manish Sadarangani; Shaun K Morris; Nicole Le Saux; Otto G Vanderkooi; James D Kellner; Gregory J Tyrrell; Irene Martin; Walter Demczuk; Scott A Halperin; Julie A Bettinger; N Bridger; Cheryl Foo; S A Halperin; K A Top; R Thibeault; D Moore; J Papenburg; M Lebel; N Le Saux; S Morris; J Embree; B Tan; Athena McConnell; T Jadavji; C Constantinescu; W Vaudry; D Scheifele; M Sadarangani; J Bettinger; L Sauvé
Journal:  Pediatr Infect Dis J       Date:  2022-04-01       Impact factor: 3.806

8.  Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales.

Authors:  Shamez N Ladhani; Mary P E Slack; Nick J Andrews; Pauline A Waight; Ray Borrow; Elizabeth Miller
Journal:  Emerg Infect Dis       Date:  2013-01       Impact factor: 6.883

9.  Exogenous re-infection by a novel Streptococcus pneumoniae serotype 14 as a cause of recurrent meningitis in a child from The Gambia.

Authors:  Martin Antonio; Claire Oluwalana; Ousman Secka; Tumani Corrah; Stephen Howie; Richard A Adegbola
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-01-20       Impact factor: 3.944

10.  Serologic response to pneumococcal vaccination in children experiencing recurrent invasive pneumococcal disease.

Authors:  Helene A S Ingels; Bjørn Kantsø; Hans-Christian Slotved
Journal:  BMC Infect Dis       Date:  2018-08-06       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.